articulos icon

Articulos

  • Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry.
  • Methods to systematically review and meta-analyses observational studies: a systematic scoping review of recommendations.
  • Real-world Data for Clinical Evidence Generation in Oncology
  • McDonald L et al. Real-World data in the United Kingdom:opportunities and challenges. BMC Medicine. 2016;14:97.
  • Albert RK. “Lies, Damned Lies . . .” and Observational Studies in Comparative Effectiveness. Am J Respir Cnt Care Med.2013;187:1173-1177
  • Lusignan S et al. Creating and using Real-World Evidence to answer questions about clinical effectiveness.J Innov Health Inform. 2015;22(3):368-73.
  • Pani L et al. Balancing access to medicines and sustainability in Europe: An analysis from the network of competent authorities on pricing and reimbursement (CAPR). Pharmacological Research 2016;111:247-50.
  • Zamorano J et al. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial. Curr Med res Opin. 2011;27(4):821-833.
  • De la Fuente C. Evaluación cualitativa y cuantitativa de los estudios posautorización de tipo observacional registrados en España. Tesis Doctoral.
  • Zamorano J et al. Design and Rationale of a Real-Life Study to Compare Treatment Strategies for Cardiovascular Risk Factors:The CRUCIAL Study. Postgrad Med. 2010;122(2)7-15.
  • Garrison LP et al. Using Real-World data for coverage and payment decisions: The ISPOR Real-World Data Task Force Report. Value Health. 2007;10(5):326-35.
  • Nieuwenhuis JB et al. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements. Epidemiol. 2016. In press.
  • Nordon C et al. The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization. Value in Health.2016;19:75-81.
  • McDonald L et al. Real-World data in the United Kingdom:opportunities and challenges. BMC Medicine. 2016;14:97.
  • Chalkidou K et al. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research. Clin Trials.2012;9:436-446.
  • Albert RK. “Lies, Damned Lies . . .” and Observational Studies in Comparative Effectiveness. Am J Respir Cnt Care Med.2013;187:1173-1177
  • Lusignan S et al. Creating and using Real-World Evidence to answer questions about clinical effectiveness.J Innov Health Inform. 2015;22(3):368-73.
  • Nieuwenhuis JB et al. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements. Epidemiol. 2016. In press.